-
Similar Survival, Safety for Bevacizumab Biosimilar vs Originator in Colorectal Cancer
08 Feb 2025 13:46 GMT
… authors noted that the treatment strategy for colorectal cancer depends on tumor characteristics … the first approved by the FDA and the second approved in … 215 in Japanese patients with colorectal cancer. Their retrospective observational study compared …
-
Are you at risk? Recognizing colorectal cancer symptoms and the importance of screening
07 Feb 2025 21:33 GMT
… or sibling) with a colorectal cancer diagnosis or precancerous polyps.
… of those diagnosed with colorectal cancer.
“Hereditary colorectal cancers … the chances of successful treatment and recovery are much … or find a clinical trial, visit Mayo Clinic.
…
-
The Future of Healthcare: Smart Pill Technology Market Set to Transform Diagnostics and Treatment
08 Feb 2025 05:58 GMT
… and medication absorption … Pharmaceutical and biotech firms are expanding research into smart pills for targeted drug … delivery and personalized treatments.
Market Segmentation
The smart pill … prevalence of colorectal cancer.
• …
-
Dr Fakih on the FDA Approval of Sotorasib Plus Panitumumab for KRAS G12C–Mutated mCRC
07 Feb 2025 19:09 GMT
… the treatment of adult patients with KRAS G12C–mutated metastatic colorectal cancer (mCRC … ), as determined by an FDA-approved test … 300 study (NCT05198934). In the trial, patients treated with sotorasib at …
-
Colorectal Cancer Screening Market Poised for Significant Growth Amid Increased Awareness and Technological Advancements
06 Feb 2025 13:55 GMT
… Food and Drug Administration (FDA) approved … and Drug Administration.
Colorectal Cancer …
Colorectal Cancer Screening and Diagnostics …
-
Colorectal Cancer Therapeutics Market to Surpass USD 22.0 Billion by 2032, Growing at a 6.2% CAGR | SNS Insider
06 Feb 2025 13:55 GMT
… Inc.
• Teva Pharmaceutical Industries Ltd.
• Taiho Pharmaceutical (Otsuka Pharmaceutical Co., Ltd.) … , increased treatment adoption, and higher drug prices, … 3 KEYFORM-007 trial, which evaluated the … for colorectal cancer. GlobalData states that the drugs in …
-
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
07 Feb 2025 09:01 GMT
… 30 days after last dose. Drug-related TEAEs referred to any … factors, diagnosis and treatment. Open Access Maced J Med Sci. 2015;3 … metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial …
-
Phase 3 Trial Shows Promising Results for Encorafenib Combination Regimen for Patients with Metastatic Colorectal Cancer
05 Feb 2025 22:57 GMT
… cetuximab and mFOLFOX6 was granted FDA accelerated approval for individuals with … identified in the phase 3 trial, serious treatment adverse events occurred in … Approval for Patients With Metastatic Colorectal Cancer. Pharmacy Times. News release. Published …
-
UAE experts may have discovered new treatment for colon cancer
07 Feb 2025 04:55 GMT
Researchers from a university in the UAE have discovered that a naturally growing aromatic plant may have the potential to treat colorectal cancer.
According to scientists from the University of Sharjah, the plant — scientifically known as Artemisia herba- …
-
Dual Immunotherapy Shows Promise in MSI-H/dMMR Metastatic Colorectal Cancer
05 Feb 2025 17:11 GMT
… CheckMate-8HW (NCT04008030) trial evaluating nivolumab (Opdivo; Bristol … drugs are a key treatment for dMMR/MSI-H colorectal cancer, … CTLA-4). The immunotherapy drug blocks CTLA-4, boosting … dMMR/MSI-H Colorectal Cancer Landscape. NIH. News release …